Founded in 2005 and based in the Lyon suburb of Saint-Priest (France), Biom’up develops and commercializes hemostatic products based on patented biopolymers designed to simplify traditional and laparoscopic surgical procedures in numerous specialties such as cardiac, general and orthopedic, and give patients a better quality of life. The Company’s lead product, HEMOBLAST™ Bellows, is marketed in Europe and the United States.
Looking for a particular Biom'up employee's phone or email?
The Biom'up annual revenue was $19.6 million in 2026.
Tom Maguire is the Vice President Regulatory Affairs and Compliance of Biom'up.
11 people are employed at Biom'up.
Biom'up is based in New York, New York.
The NAICS codes for Biom'up are [33, 339].
The SIC codes for Biom'up are [384, 38].